Skip to main content

Closed

NSRX: Nasus Pharma Ltd. Stock Analysis | finqOS

Healthcare · Medical - Pharmaceuticals

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC0.0%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-37.2×

Current ratio0.00×

Nasus Pharma Ltd.

NSRXNew York Stock Exchange Arca·USD·Closed

Nasus Pharma Ltd.

NSRXNew York Stock Exchange Arca·USD·Closed

$3.03

−4.72%

$3.03

−$0.15 (4.72%)

52W Range

13thpctl

Volume

0.15×avg

Mkt Cap

26.10MUSD

P/E

-17.8TTM

Div Yield

–ann

52W Range

13thpctl

Volume

0.15×avg

Market Cap

26.10MUSD

P/E Ratio

-17.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings